Redcare Pharmacy NV
XETRA:RDC
Redcare Pharmacy NV
XETRA:RDC
Price:
44
EUR
1.29%
Market Closed
Market Cap:
€905.5m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Redcare Pharmacy NV
XETRA:RDC
|
NL |
|
Centene Corp
NYSE:CNC
|
US |
|
Adidas AG
XETRA:ADS
|
DE |
|
FILA Fabbrica Italiana Lapis ed Affini SpA
MIL:FILA
|
IT |
|
Mulberry Group PLC
LSE:MUL
|
UK |
|
Spic Yuanda Environmental Protection Co Ltd
SSE:600292
|
CN |
|
J
|
JCU Corp
TSE:4975
|
JP |
|
Avalo Therapeutics Inc
NASDAQ:AVTX
|
US |
|
Stantec Inc
TSX:STN
|
CA |
|
Modine Manufacturing Co
NYSE:MOD
|
US |
|
G
|
Goldwind Science & Technology Co Ltd
XMUN:CXGH
|
CN |
|
L
|
Landmark Cars Ltd
NSE:LANDMARK
|
IN |
|
Natwest Group PLC
LSE:NWG
|
UK |
Wall St Price Targets
RDC Price Targets Summary
Redcare Pharmacy NV
Redcare Pharmacy NV
Wall Street analysts forecast RDC stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for RDC is 83.78 EUR with a low forecast of 40.4 EUR and a high forecast of 141.75 EUR.
Lowest Forecast
Price Target
40.4
EUR
8% Downside
Average Forecast
Price Target
83.78
EUR
90% Upside
Highest Forecast
Price Target
141.75
EUR
222% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RDC's stock price target?
Price Target
83.78
EUR
83.78
EUR
According to Wall Street analysts, the average 1-year price target for RDC is 83.78 EUR with a low forecast of 40.4 EUR and a high forecast of 141.75 EUR.
What is the Revenue forecast for Redcare Pharmacy NV?
Projected CAGR
12%
12%
Over the last 9 years, the compound annual growth rate for Revenue has been 37%. The projected CAGR for the next 5 years is 12%.
